You searched for "reconstructive"

1426 results found

Short-term instability of surgical correction of IXT

In this retrospective observation study from southern India, the authors aimed to evaluate the progression of intermittent exotropia (IXT) following surgical correction and its contributing factors in 50 patients. Mean age at surgery was 10 years (range 6–14), 26 were...

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

The results of the last survey Oct 2019

Another fascinating response which once more highlights the massive variation in practice. I completely acknowledge that ophthalmology is an art as well as a science and therefore there will be variances in practice and there will not be one ‘right’...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...

Severe conjunctival cicatrisation secondary to chronic glaucoma therapy

The timing of glaucoma filteration surgery during the course of chronic progressive glaucoma remains a contentious issue amongst glaucoma specialists. The vast majority support the use of maximal medical treatment initially to achieve the target pressure. Surgical procedures are only...

Team Arunodaya is happy to announce their August rewards!

Team Arunodaya is happy to announce that in the month of August, 2024, their doctors received the following prestigious awards.

Haag-Streit UK look forward to exhibiting at 100% Ophthalmology 2024

Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce it will be exhibiting at 100% Ophthalmology in February 2024.

Book your HS-UK equipment demonstration now for the 2026 RCOphth Annual Congress

Haag-Streit UK is excited to be exhibiting at the RCOphth Annual Congress 2026 on 18th-21st May at Manchester Central. Visit stand F40 to see key products from the HS-UK portfolio, including the new Elara slit lamp and the METIS 900...

Introducing the Surgitrac Information Hub: A New Resource for Ophthalmic Professionals

Finding reliable, practical information in ophthalmology should not feel difficult. That is why Surgitrac has launched its brand-new Information Hub, a dedicated online resource designed to support surgeons, theatre teams, nurses and procurement professionals with trusted educational content and essential...

Should points for simulated surgery be removed from the ophthalmology ST1 evidence folder?

The benefits of the Eyesi surgical simulator by Haag-Streit UK for early career ophthalmology speciality trainees are well-established, allowing for the practice of cataract and vitreoretinal surgery in a controlled, risk-free environment. Whilst the Eyesi is an invaluable resource for...

UKISOP 2023

by Lorcan Butler, Optical Engagement Manager, thebraintumourcharity.org, UKISCRS is the UK & Ireland Society of Cataract & Refractive Surgeons who had their annual Conference in London with a two-day event at The Leonardo City Hotel. On the other hand, UKISOP...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...